
ImpediMed Ltd
ASX:IPD

Intrinsic Value
The intrinsic value of one
IPD
stock under the Base Case scenario is
0.034
AUD.
Compared to the current market price of 0.039 AUD,
ImpediMed Ltd
is
Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ImpediMed Ltd
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
ImpediMed Ltd
Balance Sheet Decomposition
ImpediMed Ltd
Current Assets | 27.5m |
Cash & Short-Term Investments | 22.2m |
Receivables | 3.7m |
Other Current Assets | 1.7m |
Non-Current Assets | 14.2m |
Long-Term Investments | 73k |
PP&E | 883k |
Intangibles | 13m |
Other Non-Current Assets | 227k |
Free Cash Flow Analysis
ImpediMed Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
ImpediMed Ltd
Revenue
|
12.7m
AUD
|
Cost of Revenue
|
-1.7m
AUD
|
Gross Profit
|
11m
AUD
|
Operating Expenses
|
-34m
AUD
|
Operating Income
|
-23m
AUD
|
Other Expenses
|
-230k
AUD
|
Net Income
|
-23.2m
AUD
|
IPD Profitability Score
Profitability Due Diligence
ImpediMed Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Score
ImpediMed Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
IPD Solvency Score
Solvency Due Diligence
ImpediMed Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Score
ImpediMed Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IPD Price Targets Summary
ImpediMed Ltd
According to Wall Street analysts, the average 1-year price target for
IPD
is 0.107 AUD
with a low forecast of 0.071 AUD and a high forecast of 0.147 AUD.
Dividends
Current shareholder yield for IPD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IPD
stock under the Base Case scenario is
0.034
AUD.
Compared to the current market price of 0.039 AUD,
ImpediMed Ltd
is
Overvalued by 12%.